Immunicom, Inc.
Company Details
Status: Private
Employees: 11-50
Location:
6048 Cornerstone Court West, Suite D, San Diego, CA 92121, US
Type:
sample
sample
Technology:
sample
About: Immunicom, Inc. is a biotech company based in San Diego, CA, founded in 2013 by Amir Jafri. The company focuses on developing innovative immunotherapies, particularly through its proprietary Immunopheresis® technology platform. This technology aims to enhance the immune system's ability to fight diseases, including cancer, inflammatory, renal, and autoimmune conditions.
Immunicom's lead therapy utilizes a subtractive device to remove immune-suppressive factors from the blood, specifically targeting soluble tumor necrosis factor receptors (sTNF-R). By eliminating these barriers, the therapy seeks to restore anti-tumor activity and reactivate the immune system to effectively reduce tumor burden. The company collaborates with leading hospitals globally to conduct clinical trials, evaluating the effectiveness of its technology in various cancer treatments. Immunicom also partners with Terumo BCT to support its therapeutic apheresis equipment needs. Recently, the company received a $2 million award from the National Cancer Institute to initiate a clinical trial for its therapy in breast cancer.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Immunicom, Inc. | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.